$53.01
+0.00 (+0.00%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
-6.75%
YTD
+12.38%
Open$53.01
Previous Close$53.01
Day High$53.01
Day Low$53.01
52W High$72.88
52W Low$29.43
Volume—
Avg Volume1.80M
Market Cap2.76B
P/E Ratio28.77
EPS$1.70
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$44.35
Above
SMA 200
$63.31
Below
RSI (14)
47.2
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Hold
16 analysts
Price Target
-62.4% upside
Current
$53.01
$53.01
Target
$19.95
$19.95
$16.99
$19.95 avg
$27.29
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 189.44M | 785.64M | 787.82M |
| Net Income | 20.79M | 73.80M | 76.85M |
| Profit Margin | 11.0% | 9.4% | 9.8% |
| EBITDA | 11.37M | 123.66M | 121.59M |
| Free Cash Flow | — | 65.88M | 73.67M |
| Rev Growth | +298.9% | +24.2% | +9.0% |
| Debt/Equity | 0.11 | 0.21 | 0.24 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |